Palvella Therapeutics, Inc.
PVLA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $84 | $7 | $16 | $118 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $0 | $0 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $0 | $0 | $7 |
| Total Curr. Assets | $88 | $8 | $17 | $128 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $23 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $3 |
| Total NC Assets | $0 | $0 | $0 | $26 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $88 | $8 | $17 | $154 |
| Liabilities | – | – | – | – |
| Payables | $5 | $1 | $3 | $9 |
| Short-Term Debt | $0 | $0 | $0 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $25 |
| Other Curr. Liab. | $7 | $1 | $3 | $16 |
| Total Curr. Liab. | $12 | $2 | $6 | $51 |
| LT Debt | $0 | $0 | $0 | $14 |
| Deferred Rev, NC | $0 | $0 | $0 | $38 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $14 | $9 | $34 | $0 |
| Total NC Liab. | $14 | $9 | $34 | $52 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $14 |
| Total Liabilities | $26 | $11 | $40 | $103 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $71 | $71 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$94 | -$76 | -$95 | -$257 |
| AOCI | $0 | $0 | $0 | $1 |
| Other Equity | $156 | $2 | $1 | $307 |
| Total Equity | $63 | -$4 | -$23 | $51 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $88 | $8 | $17 | $154 |
| Net Debt | -$84 | -$7 | -$16 | -$103 |